APA (7th ed.) Citation

W, L., Y, L., Y, K., X, G., X, Y., J, L., . . . Y, C. (2026). PRMT1-mediated asymmetric dimethylation of arginine residue 602 in DDX1 promotes cholangiocarcinoma progression. Clinical and molecular hepatology, 32(2), 843. https://doi.org/10.3350/cmh.2025.1252

Chicago Style (17th ed.) Citation

W, Liu, et al. "PRMT1-mediated Asymmetric Dimethylation of Arginine Residue 602 in DDX1 Promotes Cholangiocarcinoma Progression." Clinical and Molecular Hepatology 32, no. 2 (2026): 843. https://doi.org/10.3350/cmh.2025.1252.

MLA (9th ed.) Citation

W, Liu, et al. "PRMT1-mediated Asymmetric Dimethylation of Arginine Residue 602 in DDX1 Promotes Cholangiocarcinoma Progression." Clinical and Molecular Hepatology, vol. 32, no. 2, 2026, p. 843, https://doi.org/10.3350/cmh.2025.1252.